Robert Schultz
Corporate Officer/Principal at SATSUMA PHARMACEUTICALS, INC.
Network origin in Robert Schultz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Schultz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Corporate Officer/Principal | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Corporate Officer/Principal | |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Portfolio Manager-Equities | |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Miscellaneous Commercial Services | Chief Executive Officer Sales & Marketing Chief Operating Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
SurroMed, Inc.
 SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Biotechnology | Corporate Officer/Principal | |
| Big Brothers Big Sisters of Massachusetts Bay | Corporate Officer/Principal | ||
Symphony ViDA, Inc.
 Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member | |
| SNBL Clinical Pharmacology Center, Inc. | Chairman Director/Board Member | ||
SNBL USA Ltd.
 SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Medical/Nursing Services | Chairman Director of Finance/CFO | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
Medipolis Medical Research Institute
 Medipolis Medical Research Institute Medical/Nursing ServicesHealth Services Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Chairman Director/Board Member | |
SNBL China, Ltd.
 SNBL China, Ltd. Agricultural Commodities/MillingProcess Industries Part of Pharmaron Beijing Co., Ltd., SNBL China, Ltd. breeds and sells laboratory animals. The company is based in Zhaoqing, China. The Chinese company was founded in 2003. The CEO is Yan Wei Liu. SNBL China was acquired by Pharmaron Beijing Co., Ltd. from Shin Nippon Biomedical Laboratories, Ltd. on April 30, 2021. | Agricultural Commodities/Milling | Chairman Director/Board Member | |
Ekteino Laboratories, Inc.
 Ekteino Laboratories, Inc. BiotechnologyHealth Technology Ekteino Laboratories, Inc. develops sustained-release drug delivery systems for chronic use medications. The private company is based in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ceribell, Inc.
 Ceribell, Inc. Medical SpecialtiesHealth Technology Ceribell, Inc. engages in the development of diagnosis medical devices. The firm focuses on making electroencephalography (EEG) for diagnosis and treatment of patients at risk for seizures. Its products include Ceribell EEG headband, Ceribell EEG recorder, and spot-checks with brain stethoscope. The company was founded by Jane Chao, Josef Parvizi and Chris Chafe in 2014 and is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
PPD-SNBL KK
 PPD-SNBL KK Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., PPD-SNBL KK is a Japanese company that provides clinical research services. The company is based in Tokyo, Japan. | Miscellaneous Commercial Services | President Comptroller/Controller/Auditor | |
| EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Investment Managers | Founder | |
| VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| Texas Radiological Society | Director/Board Member | ||
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 45 |
| Japan | 5 |
| United Kingdom | 2 |
| China | 2 |
Sectoral
| Health Technology | 33 |
| Finance | 5 |
| Commercial Services | 5 |
| Consumer Services | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 143 |
| Corporate Officer/Principal | 84 |
| Independent Dir/Board Member | 42 |
| Chairman | 29 |
| Chief Executive Officer | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Heath Lukatch | 43 |
| Perry Karsen | 38 |
| Howard Rosen | 26 |
| Sundar Kodiyalam | 21 |
| Thomas King | 16 |
| Raj Shah | 16 |
| Thomas O'Neil | 15 |
| Kevin Thomas Ferro | 15 |
| Ryoichi Nagata | 15 |
| John Kollins | 15 |
| Charles Bramlage | 13 |
| Ken Takanashi | 13 |
| Thomas Soloway | 12 |
| Elisabeth Sandoval | 12 |
| Detlef F. Albrecht | 10 |
- Stock Market
- Insiders
- Robert Schultz
- Company connections